Reply:

References

1. 1.↵
   2. Shaffer JL,
   3. Petrella JR,
   4. Sheldon FC, et al

   ; Alzheimer's Disease Neuroimaging Initiative. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 2013;266:583–91 doi:10.1148/radiol.12120010 pmid:23232293

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Hostage CA,
   3. Choudhury KR,
   4. Murali Doraiswamy P, et al

   ; Alzheimer's Disease Neuroimaging Initiative. Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network. Radiology 2014;271:211–19 doi:10.1148/radiol.13131041 pmid:24475827

   CrossRefPubMed
3. 3.↵
   2. Albert MS,
   3. DeKosky ST,
   4. Dickson D, et al

   . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270–79 doi:10.1016/j.jalz.2011.03.008 pmid:21514249

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Petrella JR

   . Neuroimaging and the search for a cure for Alzheimer disease. Radiology 2013;269:671–91 doi:10.1148/radiol.13122503 pmid:24261497

   CrossRefPubMed